在状细胞疾病中治疗血栓炎症的异克尔塞丁:一项随机双盲,安慰剂对照的随机试验
Maria A Lizarralde-Iragorri1, Bindu Parachalil Gopalan1, Brenda Merriweather2
1Sickle Thrombosis and Vascular Biology Lab, Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD.
Blood advances
|December 29, 2023
概括
伊索克尔塞丁 (IQ) 在状细胞病 (SCD) 患者中显示出安全性,减少了血栓炎症生物标志物,如凝血和血小板聚合. 虽然不影响溶性P-选择素,但IQ为SCD管理提供了一个有前途的途径.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 状细胞病 (SCD) 与增加的血栓炎症有关.
- 易索克尔塞丁 (IQ) 是一种黄类化合物,在癌症患者中显示出降低血栓形成生物标志物的潜力.
- 有限的研究存在于智商的有效性在针对成年人SCD的血栓炎症.
研究的目的:
- 评估伊索克尔塞丁 (IQ) 对状细胞疾病 (SCD) 的成年人血栓炎症生物标志物的作用.
- 在这个患者群体中评估智商的安全性和耐受性.
- 调查智商对血溶性P-选择素 (sP-选择素) 的影响作为主要结果.
主要方法:
- 一个随机,双盲,安慰剂对照试验,涉及46名患有稳定状态SCD的成年人.
- 参与者接受了智商 (n=23) 或安慰剂 (n=23).
- 主要结局:与基线相比,血sP-选择素的变化;次要结局包括凝血,血小板聚合和组织因子表达.
主要成果:
- 智商被很好地容忍,没有药物引起的不良事件.
- 在智商和安慰剂组之间没有观察到sP-选择因水平的显著差异.
- 智商显著降低了全血凝结,原诱导的血小板聚合,并抑制了单核细胞组织因子基因表达和蛋白质二硫酸异构酶减少酶活性.
结论:
- 短期,固定剂量智商在成人SCD患者中是安全的,没有观察到异常出血.
- 在SCD中,智商证明了几个关键的血栓炎症生物标志物的有利调节.
- 需要进一步的研究来探索智商在治疗SCD并发症方面的治疗潜力.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


